Top Markets
#1 EXOD EXOD +22.08%
#2 Status Status +11.36%
#3 The Bitcoin Bull The Bitcoin Bull +5.66%
#4 Tornado Cash Tornado Cash +5.29%
#5 BCGame Coin BCGame Coin +5.00%
#6 B3 (Base) B3 (Base) +4.43%
#7 MarsCoin MarsCoin +3.79%
#8 Gas Gas +3.76%
#9 Fake World Assets Fake World Assets +3.61%
#10 The Black Bull The Black Bull +3.12%
Coin of the day
EXOD EXOD
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
LianBio LianBio

LianBio

LIAN
शेयरों में रैंक #25845
LianBio is a biopharmaceutical firm dedicated to advancing and commercializing... LianBio is a biopharmaceutical firm dedicated to advancing and commercializing medical treatments for a broad spectrum of conditions, encompassing cardiovascular, oncological, respiratory, ophthalmic, and inflammatory diseases. Its primary operational focus is in China and other Asian nations. The company's development pipeline features several investigational therapies: mavacamten, aimed at addressing obstructive and non-obstructive hypertrophic cardiomyopathy, as well as heart failure with preserved ejection fraction; TP-03, for the treatment of Demodex blepharitis; NBTXR3, targeting head and neck squamous cell carcinoma and other solid tumors; Infigratinib, for first-line and second-line cholangiocarcinoma and gastric cancers; BBP-398, also for solid tumors; Omilancor and NX-13, both indicated for ulcerative colitis (with Omilancor additionally for Crohn's disease); LYR-210, for chronic rhinosinusitis; and Sisunatovir, under investigation for respiratory syncytial virus. To further its drug candidates, LianBio has established strategic alliances, including a collaboration with Tarsus Pharmaceuticals, Inc. for the development and commercialization of TP-03, an eye solution for Demodex blepharitis. They also partner with Nanobiotix S.A. for NBTXR3, a radioenhancer designed to be directly administered into malignant tumors before standard radiation therapy. The company was founded in 2019 and is headquartered in Princeton, New Jersey.
शेयर मूल्य
$0.42275
अंतिम समन्वयन: 2025-07-14
मार्केट कैप
$45.81M
बदलाव (1 दिन)
-0.89%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार LianBio (LIAN)

श्रेणी

Healthcare
LianBio (LIAN) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.42 (2025-07-01 को)

दिन का सबसे निम्न समापन मूल्य: $14.58 (2021-11-01 को)
LianBio के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2025 44.04%
2024 -93.17%
2023 184.09%
2022 -82.11%
2021 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -16.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US